mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.006 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.007 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.008 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.008 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.008 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.008 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.009 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.009 |